|
Clinical Trial
Looking for Clinical Trial? Search over 15,000 sites with one clicks. Your source for everything under the sun! www.findstuff.com Healthcare Product Regulatory Professionals To Convene In Boston For ... - Forbes rockville, md., sept. 10 /prnewswire-usnewswire/ -- regulatory professionals from more than 25 countries will converge on boston next week for the regulatory affairs professionals society's (raps) 2008 annual conference & exhibition. the annual event ... www.forbes.com Gtx To Present Additional Efficacy And Safety Analyses From The Toremifene 80 Mg Phase Iii Adt Clinical Trial At The ... memphis, tenn.----gtx, inc. announced that additional efficacy and safety analyses from the phase iii clinical trial evaluating toremifene 80 mg for the treatment of multiple side effects of androgen deprivation therapy in men with advanced prostate cancer will be presented september 16th in an oral session at the 2008 annual meeting of the american society for bone and mineral research being ... biz.yahoo.com Progenics Initiates Phase 1 Clinical Study Of Targeted Therapy For Prostate Cancer progenics pharmaceuticals, inc. (nasdaq: pgnx) announced the initiation of a phase 1 dose-escalation clinical study of its prostate-specific membrane antigen (psma) antibody-drug conjugate (adc). psma adc is an investigational therapy that combines a prostate-cancer antibody with a cancer drug. www.medicalnewstoday.com Study Published In New England Journal Of Medicine Shows Erbitux(r ... - Forbes imclone systems incorporated (nasdaq: imcl) and bristol-myers squibb company (nyse: bmy) today announced the publication of results from a phase 3 trial in the new england journal of medicine of erbitux(r) (cetuximab) plus platinum-based chemotherapy ... www.forbes.com As Head And Neck Cancer Risks Evolve, More Treatment Options Emerge - Genetic Engineering News advances in understanding head and neck cancer over the last decade have led to more treatment options and improved quality of life for patients, according to a review published this week in the new england journal of medicine . the authors are dong ... www.genengnews.com New Approach Uses A Common Virus To Combat Deadly Lung Cancer among the 5,000 studies being discussed by 30,000 oncologists at the 2008 meeting of the american society of clinical oncology (asco), a great deal of buzz was generated over the discovery that a substantial subset of patients with non-small cell lung cancer (nsclc) may not benefit from the most commonly prescribed therapies. www.medicalnewstoday.com Cytokinetics Announces Interim Clinical Trial Data Relating To Ispinesib Presented At The 2008 Asco Breast Cancer ... cytokinetics, incorporated announced that data from its ongoing phase i/ii clinical trial of ispinesib were presented in a poster at the 2008 american society of clinical oncology breast cancer symposium held on september 5-7, 2008 in washington, dc. biz.yahoo.com Trials To Begin On Hay Fever Drug - Channel 4 News human trials are to begin on a new drug to treat asthma and hay fever, it has been announced. the drug firm verona pharma said it had signed a contract to begin clinical trials with its potentially "ground-breaking" rpl554 drug. if successful in ... www.channel4.com Cvbt Announces First Site To Begin Patient Enrollment For Its Phase Ii ... - Msn Moneycentral las vegas , sept. 9 /prnewswire-firstcall/ -- cardiovascular biotherapeutics, inc. (otc bulletin board: cvbt) today announces that its first us site is open for patient enrollment for its phase ii clinical trial for the treatment of severe coronary ... news.moneycentral.msn.com Roche To Present Data Showing Progress In Treating Lung, Gastric And Brain Cancers At Esmo more than 100 roche abstracts have been accepted for the biggest cancer congress in europe, the european society for medical oncology , which opens in stockholm on friday . the roche abstracts include the latest data on avastin , herceptin , tarceva , xeloda and the new breast cancer drug, pertuzumab, which is currently in phase iii trials. biz.yahoo.com Immune-modulating Effects Of Cold-fx(r) Shown In Clinical Trial: edmonton, alberta-- - cv technologies inc. today announced preliminary results suggesting that cold-fx affects the human immune system by targeting the adaptive pathway, which is the immunity developed throughout life. biz.yahoo.com Sleight Of Hand - Chicago Sun-times maybe you wouldn't have noticed it. but it bothered laura garcia no end: one of her earring holes was stretched out. "i was wearing hoops back in the '90s, and i had my little cousin on my lap," says garcia. sure enough, he reached up and yanked on ... www.suntimes.com Immune-modulating Effects Of Cold-fx ® Shown In Clinical Trial: - Market Wire edmonton, alberta--(marketwire - sept. 10, 2008) - cv technologies inc. (tsx:cvq) today announced preliminary results suggesting that cold-fx ® affects the human immune system by targeting the adaptive pathway, which is the immunity developed ... www.marketwire.com New Data From A Phase 3 Study Confirms Clinical Benefits Of Once-daily Liraglutide In The Management Of Type 2 Diabetes data from a phase 3 clinical study (lead™ 4) presented at the 44th annual meeting of the european association for the study of diabetes (easd) demonstrated that adding the investigational new drug liraglutide, a human glp-1 analogue, to metformin and rosiglitazone in the treatment of type 2 dia www.medicalnewstoday.com Infectious Heart Disease Death Rates Rising Again Say Scientists infectious heart disease is still a major killer in spite of improvements in health care, but the way the disease develops has changed so much since its discovery that nineteenth century doctors would not recognize it, scientists heard today at the society for general microbiology's autumn meeting being held this week at trinity college, dublin. www.eurekalert.org New Treatment For Chronic Hand Eczema Launched In Uk - Toctino(r ... - Medical News Today toctino® (alitretinoin), a new once-daily oral capsule licensed for the treatment of adults with severe chronic hand eczema (che) that is unresponsive to potent topical corticosteroids, is now available in the uk. many patients with severe chronic ... www.medicalnewstoday.com National Institute On Drug Abuse Announces Recipients Of New Avant ... - Medical News Today the national institute on drug abuse (nida), part of the national institutes of health, announced the first three recipients of its new avant-garde award. this award is intended to stimulate high-impact research that may lead to groundbreaking ... www.medicalnewstoday.com Cvbt Announces First Site To Begin Patient Enrollment For Its Phase Ii Heart Trial cardiovascular biotherapeutics, inc. (otc bulletin board: cvbt) announces that its first us site is open for patient enrollment for its phase ii clinical trial for the treatment of severe coronary heart disease. in the coming weeks, cvbt anticipates announcing additional sites as they open for enrollment. www.medicalnewstoday.com Infectious Heart Disease Death Rates Rising Again Say Scientists infectious heart disease is still a major killer in spite of improvements in health care, but the way the disease develops has changed so much since its discovery that nineteenth century doctors would not recognise it, scientists heard today (thursday 11 september 2008) at the society for general microbiology's autumn meeting being held this week at trinity college, dublin. www.news-medical.net Creating Lung Cancer Risk Models For Specific Populations Refines ... - Science Daily sciencedaily (sep. 9, 2008) — lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring dna repair capacity, according to research teams led by epidemiologists at the university of texas m. d ... www.sciencedaily.com |